1. Home
  2. BNKK vs TPST Comparison

BNKK vs TPST Comparison

Compare BNKK & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNKK
  • TPST
  • Stock Information
  • Founded
  • BNKK 2018
  • TPST 2011
  • Country
  • BNKK United States
  • TPST United States
  • Employees
  • BNKK N/A
  • TPST N/A
  • Industry
  • BNKK Package Goods/Cosmetics
  • TPST Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNKK Consumer Discretionary
  • TPST Health Care
  • Exchange
  • BNKK Nasdaq
  • TPST Nasdaq
  • Market Cap
  • BNKK 38.6M
  • TPST 42.3M
  • IPO Year
  • BNKK 2020
  • TPST N/A
  • Fundamental
  • Price
  • BNKK $0.15
  • TPST $4.81
  • Analyst Decision
  • BNKK
  • TPST Hold
  • Analyst Count
  • BNKK 0
  • TPST 2
  • Target Price
  • BNKK N/A
  • TPST $12.50
  • AVG Volume (30 Days)
  • BNKK 4.4M
  • TPST 75.9K
  • Earning Date
  • BNKK 11-14-2025
  • TPST 11-05-2025
  • Dividend Yield
  • BNKK N/A
  • TPST N/A
  • EPS Growth
  • BNKK N/A
  • TPST N/A
  • EPS
  • BNKK N/A
  • TPST N/A
  • Revenue
  • BNKK N/A
  • TPST N/A
  • Revenue This Year
  • BNKK N/A
  • TPST N/A
  • Revenue Next Year
  • BNKK N/A
  • TPST N/A
  • P/E Ratio
  • BNKK N/A
  • TPST N/A
  • Revenue Growth
  • BNKK 246.36
  • TPST N/A
  • 52 Week Low
  • BNKK $0.13
  • TPST $4.50
  • 52 Week High
  • BNKK $1.34
  • TPST $13.65
  • Technical
  • Relative Strength Index (RSI)
  • BNKK N/A
  • TPST 21.27
  • Support Level
  • BNKK N/A
  • TPST $8.51
  • Resistance Level
  • BNKK N/A
  • TPST $9.75
  • Average True Range (ATR)
  • BNKK 0.00
  • TPST 0.98
  • MACD
  • BNKK 0.00
  • TPST -0.35
  • Stochastic Oscillator
  • BNKK 0.00
  • TPST 4.50

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: